Literature DB >> 3156933

Opsonic properties of C-reactive protein. Stimulation by phorbol myristate acetate enables human neutrophils to phagocytize C-reactive protein-coated cells.

J M Kilpatrick, J E Volanakis.   

Abstract

We examined phagocytosis of sheep erythrocytes passively sensitized with pneumococcal C-polysaccharide (E-PnC) and of E-PnC coated with C-reactive protein (E-PnC-CRP) by human polymorphonuclear leukocytes (PMN). PMN isolated from blood of normal individuals failed to ingest either E-PnC or E-PnC-CRP; however, after stimulation with 12-O-tetradecanoylphorbol-13-acetate (PMA; 2 ng/ml), PMN ingested E-PnC-CRP efficiently with a mean phagocytic index (PI) of 99.5 +/- 4.8 (mean +/- SD, n = 11), and E-PnC to a lesser extent with a mean PI of 33.2 +/- 11.7 (mean +/- SD, n = 11). PMN that had adhered to PnC-coated glass and that were stimulated with PMA attached but did not ingest E-PnC-CRP. In contrast, PMN plated on E-PnC-CRP-coated glass and stimulated with PMA did not attach or ingest E-PnC-CRP. These data indicate that PMN can be induced to phagocytize PnC-CRP and that both PnC and CRP are required for ingestion. They also suggest that specific receptors for these ligands are expressed by stimulated PMN. Neither attachment nor phagocytosis of E coated with rabbit anti-E IgG (E-IgG) was affected by plating PMN on PnC or PnC-CRP. On the other hand, both phagocytosis and ingestion of E-PnC-CRP as well as E-IgG was blocked by plating PMA-stimulated PMN on immune complexes containing rabbit IgG. Inhibition experiments with the use of 3G8, a monoclonal antibody to the Fc gamma receptor of PMN, and human monomeric IgG1 demonstrated that attachment of E-PnC-CRP is mediated by receptors other than the Fc gamma receptors. These combined results indicated a nonreciprocal association between the putative CRP receptors and the Fc gamma receptors of stimulated PMN, resulting in the clearance of both types of receptors from the apical surface of PMN by antigen-immobilized rabbit IgG.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3156933

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

Review 1.  Molecular genetics, structure, and function of C-reactive protein.

Authors:  J M Kilpatrick; J E Volanakis
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

2.  Serum amyloid P-component-induced enhancement of macrophage listericidal activity.

Authors:  P P Singh; F Gervais; E Skamene; R F Mortensen
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

3.  Role of complement in C-reactive-protein-mediated protection of mice from Streptococcus pneumoniae.

Authors:  A J Szalai; D E Briles; J E Volanakis
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

4.  C-reactive protein-mediated phagocytosis and phospholipase D signalling through the high-affinity receptor for immunoglobulin G (FcgammaRI).

Authors:  Katherine B Bodman-Smith; Alirio J Melendez; Ian Campbell; Patrick T Harrison; Janet M Allen; John G Raynes
Journal:  Immunology       Date:  2002-10       Impact factor: 7.397

5.  C-reactive protein binding to FcgammaRIIa on human monocytes and neutrophils is allele-specific.

Authors:  M P Stein; J C Edberg; R P Kimberly; E K Mangan; D Bharadwaj; C Mold; T W Du Clos
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

6.  Role of C-reactive protein in complement-mediated hemolysis in Malaria.

Authors:  Waliza Ansar; Sumi Mukhopadhyay Nee Bandyopadhyay; Suchandra Chowdhury; Sk Hasan Habib; Chitra Mandal
Journal:  Glycoconj J       Date:  2006-05       Impact factor: 2.916

7.  Characterization of neutrophil-mediated degradation of human C-reactive protein and identification of the protease.

Authors:  E G Shephard; S L Kelly; R Anderson; M Fridkin
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

8.  Therapeutic effects of a synthetic peptide of C-reactive protein in pre-clinical tumor models.

Authors:  B P Barna; D A Eppstein; M J Thomassen; J J Nestor; T Ho; S V Medendorp; S D Deodhar
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

9.  The hepatitis E virus ORF3 protein modulates epidermal growth factor receptor trafficking, STAT3 translocation, and the acute-phase response.

Authors:  Vivek Chandra; Anindita Kar-Roy; Sudha Kumari; Satyajit Mayor; Shahid Jameel
Journal:  J Virol       Date:  2008-04-30       Impact factor: 5.103

10.  CRP and neutrophils: functional effects and complex uptake.

Authors:  E G Shephard; R Anderson; A F Strachan; S H Kühn; F C De Beer
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.